Epidemiology of systemic lupus erythematosus
- Guillermo J. Pons-Estel,
- ,
- Graciela S. Alarcón(corresponding author)
- Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR),
- Hospital Clinic Barcelona,
- ,
- Universidad Científica del Sur,
- Hospital Guillermo Almenara Irigoyen,
- The University of Alabama at Birmingham
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 799-814 (16 pages)Journal (Volume, Issue Number)
Expert Review of Clinical Immunology (Volume 13, Issue 8)Publication milestones
- Published - 03/08/2017
Publication status
ISSN
1744-666XPublication IDs
- Scopus: 85024505003
- PubMed: 28471259
Abstract
Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which occurs in both genders, and across racial/ethnic and age groups; however, higher rates are observed in adults, in women and in non-Caucasians. Genetic, environmental, sociodemographic and methodological issues are responsible not only for these differences but for the variable course and outcome of the disease. Non-Caucasians have a more severe disease with a higher risk for early mortality and damage accrual. Males also have a more severe disease; however, a negative impact of male gender on lupus outcomes has not been firmly established. Childhood-onset is associated with a more severe disease; moreover, it is also associated with higher damage and diminished survival; finally, late-onset lupus is mild but it is associated with higher damage accrual and a diminished survival. Areas covered: In this review, we discuss the incidence and prevalence of SLE, the impact of age, gender and race/ethnicity in SLE and in the survival of those affected. Expert commentary: Age, gender and race/ethnicity impact disease expression in SLE patients; despite improvements in survival, mortality in SLE remains almost three times higher than in the general population.
